1. Home
  2. DNLI vs DQ Comparison

DNLI vs DQ Comparison

Compare DNLI & DQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • DQ
  • Stock Information
  • Founded
  • DNLI 2013
  • DQ 2006
  • Country
  • DNLI United States
  • DQ China
  • Employees
  • DNLI N/A
  • DQ N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • DQ Semiconductors
  • Sector
  • DNLI Health Care
  • DQ Technology
  • Exchange
  • DNLI Nasdaq
  • DQ Nasdaq
  • Market Cap
  • DNLI 2.2B
  • DQ 2.0B
  • IPO Year
  • DNLI 2017
  • DQ 2010
  • Fundamental
  • Price
  • DNLI $14.93
  • DQ $31.21
  • Analyst Decision
  • DNLI Strong Buy
  • DQ Buy
  • Analyst Count
  • DNLI 13
  • DQ 4
  • Target Price
  • DNLI $32.64
  • DQ $32.50
  • AVG Volume (30 Days)
  • DNLI 1.5M
  • DQ 1.2M
  • Earning Date
  • DNLI 11-03-2025
  • DQ 10-27-2025
  • Dividend Yield
  • DNLI N/A
  • DQ N/A
  • EPS Growth
  • DNLI N/A
  • DQ N/A
  • EPS
  • DNLI N/A
  • DQ N/A
  • Revenue
  • DNLI N/A
  • DQ $639,063,000.00
  • Revenue This Year
  • DNLI N/A
  • DQ N/A
  • Revenue Next Year
  • DNLI $94,232.03
  • DQ $78.53
  • P/E Ratio
  • DNLI N/A
  • DQ N/A
  • Revenue Growth
  • DNLI N/A
  • DQ N/A
  • 52 Week Low
  • DNLI $10.57
  • DQ $12.41
  • 52 Week High
  • DNLI $33.33
  • DQ $34.21
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 42.86
  • DQ 59.80
  • Support Level
  • DNLI $15.53
  • DQ $28.55
  • Resistance Level
  • DNLI $17.02
  • DQ $34.21
  • Average True Range (ATR)
  • DNLI 0.79
  • DQ 1.86
  • MACD
  • DNLI -0.19
  • DQ 0.49
  • Stochastic Oscillator
  • DNLI 0.71
  • DQ 68.04

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About DQ DAQO New Energy Corp.

Daqo New Energy Corp is a polysilicon manufacturer based in China. The company manufactures and sells high-purity polysilicon to manufacturers who use it to make ingots, cells, and modules for solar power solutions. The polysilicon is packaged to meet crucible stacking, pulling, and solidification needs. All of the company's revenues come from the People's Republic of China.

Share on Social Networks: